Patient Anxiety During Magnetic Resonance Imaging
ConditionCancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEuropean Institute of Oncology
About this trial
This study is a cross-sectional validation project that aims to translate the MRI-Anxiety Questionnaire (MRI-AQ) into Italian and adapt it culturally for cancer patients undergoing whole-body MRI. The protocol will recruit 175 adult patients at the European Institute of Oncology, use a forward-backward translation process, and evaluate the Italian version with the MRI-AQ itself plus the MRI Fear Survey Schedule (MRI-FSS). The main statistical goal is to show that the Italian version is not inferior to the original in terms of internal consistency. The ultimate purpose is to provide a specific, validated tool for measuring MRI-related anxiety in Italian oncology patients.
Eligibility criteria
Qualifiers
Cancer patients who will perform a WB-MRI in their clinical path
Age ≥ 18 years
Patients able to speak and read the local language(s) fluently.
Patients with no concomitant neurological or psychiatric disorders.
Disqualifiers
Absolute contraindication to WB-MRI
Previous cancer-related medical treatments or other treatments that could have altered patients' cognition
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1European Institute of Oncology, Milan20141, MilanMi, Italy
Sponsors and collaborators
European Institute of Oncology
Lead sponsor
Source ClinicalTrials.gov